Stay updated on VX-659 Combo in F/MF CF: Clinical Trial
Sign up to get notified when there's something new on the VX-659 Combo in F/MF CF: Clinical Trial page.

Latest updates to the VX-659 Combo in F/MF CF: Clinical Trial page
- Check6 days agoChange Detected- Revision: v3.4.1 released, replacing v3.4.0. No substantive changes to the study details or page functionality are evident.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Study Details page now includes an expanded list of study locations (US states and Canadian provinces) and adds a revision tag (v3.3.3). The HHS Vulnerability Disclosure link and the previous set of location entries were removed.SummaryDifference2%

- Check78 days agoChange DetectedRevision label on the page was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check85 days agoChange DetectedNotice regarding government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check100 days agoChange DetectedMinor UI/layout adjustments are visible in the Study Overview and Study Plan sections; the core study data such as title, inclusion criteria, primary outcomes, and enrollment remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to VX-659 Combo in F/MF CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-659 Combo in F/MF CF: Clinical Trial page.